Mark Austin - VP Finance/Prin Fin&Acct Offic at Perspective Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP Finance/Prin Fin&Acct Offic
Issuer Symbol
CATX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Austin since 23 Jan 2025

Holdings reported by Mark Austin for Perspective Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 84,030 $30,251 $0.3600 23 Apr 2024 Direct
Stock Option (right to buy) 34,500 17 Jul 2024 Direct Common Stock

Transactions reported by Mark Austin for Perspective Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.